I. Endo, M. Gonen, and A. Yopp, Intrahepatic Cholangiocarcinoma, Annals of Surgery, vol.248, issue.1, pp.84-96, 2008.
DOI : 10.1097/SLA.0b013e318176c4d3

S. Rizvi and G. Gores, Pathogenesis, Diagnosis, and Management of Cholangiocarcinoma, Gastroenterology, vol.145, issue.6, pp.1215-1244, 2013.
DOI : 10.1053/j.gastro.2013.10.013

R. Siegel, J. Ma, Z. Zou, and A. Jemal, Cancer statistics, 2014, CA: A Cancer Journal for Clinicians, vol.112, issue.suppl 5, pp.9-29, 2014.
DOI : 10.3322/caac.21208

R. Dodson, M. Weiss, and D. Cosgrove, Intrahepatic Cholangiocarcinoma: Management Options and Emerging Therapies, Journal of the American College of Surgeons, vol.217, issue.4, pp.736-750, 2013.
DOI : 10.1016/j.jamcollsurg.2013.05.021

T. Patel, Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States, Hepatology, vol.33, issue.6, pp.1353-1360, 2001.
DOI : 10.1053/jhep.2001.25087

O. Farges and D. Fuks, Clinical presentation and management of intrahepatic cholangiocarcinoma, Gastroent??rologie Clinique et Biologique, vol.34, issue.3, pp.191-200, 2010.
DOI : 10.1016/j.gcb.2010.01.006

J. Tan, N. Coburn, and N. Baxter, Surgical Management of Intrahepatic Cholangiocarcinoma - A Population-Based Study, Annals of Surgical Oncology, vol.70, issue.2, pp.600-608, 2008.
DOI : 10.1245/s10434-007-9627-x

H. Nathan, T. Pawlik, and C. Wolfgang, Trends in Survival after Surgery for Cholangiocarcinoma: A 30-Year Population-Based SEER Database Analysis, Journal of Gastrointestinal Surgery, vol.20, issue.6, pp.1488-96, 2007.
DOI : 10.1007/s11605-007-0282-0

M. Ohtsuka, H. Ito, and F. Kimura, Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival, British Journal of Surgery, vol.166, issue.12, pp.1525-1556, 2002.
DOI : 10.1046/j.1365-2168.2002.02268.x

J. Geschwind, R. Salem, and B. Carr, Yttrium-90 microspheres for the treatment of hepatocellular carcinoma, Gastroenterology, vol.127, issue.5, pp.194-205, 2004.
DOI : 10.1053/j.gastro.2004.09.034

M. Vente, M. Wondergem, and I. Van-der-tweel, Yttrium-90 microsphere radioembolization for the treatment of liver malignancies: a structured meta-analysis, European Radiology, vol.23, issue.Suppl 1, pp.951-960, 2009.
DOI : 10.1007/s00330-008-1211-7

S. Ibrahim, M. Mulcahy, and R. Lewandowski, Treatment of unresectable cholangiocarcinoma using yttrium-90 microspheres, Cancer, vol.18, issue.8, pp.2119-2147, 2008.
DOI : 10.1002/cncr.23818

A. Saxena, L. Bester, and T. Chua, Yttrium-90 Radiotherapy for Unresectable Intrahepatic Cholangiocarcinoma: A Preliminary Assessment of This Novel Treatment Option, Annals of Surgical Oncology, vol.16, issue.9493, pp.484-91, 2010.
DOI : 10.1245/s10434-009-0777-x

S. Rafi, S. Piduru, and B. El-rayes, Yttrium-90 radioembolization for unresectable standardchemorefractory intrahepatic cholangiocarcinoma: survival, efficacy, and safety study

S. Mouli, K. Memon, and T. Baker, Yttrium-90 Radioembolization for Intrahepatic Cholangiocarcinoma: Safety, Response, and Survival Analysis, Journal of Vascular and Interventional Radiology, vol.24, issue.8, pp.1227-1261, 2013.
DOI : 10.1016/j.jvir.2013.02.031

J. Edeline, L. Lenoir, and K. Boudjema, Volumetric Changes after 90Y Radioembolization for Hepatocellular Carcinoma in Cirrhosis: An Option to Portal Vein Embolization in a Preoperative Setting?, Annals of Surgical Oncology, vol.118, issue.497???507, pp.2518-2543, 2013.
DOI : 10.1245/s10434-013-2906-9

M. Oken, R. Creech, and D. Tormey, Toxicity and response criteria of the Eastern Cooperative Oncology Group, AMERICAN JOURNAL OF CLINICAL ONCOLOGY, vol.5, issue.6, pp.649-55, 1982.
DOI : 10.1097/00000421-198212000-00014

S. Strasberg and C. Phillips, Use and Dissemination of the Brisbane 2000 Nomenclature of Liver Anatomy and Resections, Annals of Surgery, vol.257, issue.3, pp.377-82, 2013.
DOI : 10.1097/SLA.0b013e31825a01f6

F. Chou, S. Sheen-chen, and Y. Chen, Surgical treatment of cholangiocarcinoma, Hepatogastroenterology, vol.44, pp.760-765, 1997.

J. Valle, H. Wasan, and D. Palmer, Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer, New England Journal of Medicine, vol.362, issue.14, pp.1273-81, 2010.
DOI : 10.1056/NEJMoa0908721

T. Kiba, T. Nishimura, and S. Matsumoto, Single-Agent Gemcitabine for Biliary Tract Cancers, Oncology, vol.70, issue.5, pp.358-65, 2006.
DOI : 10.1159/000098109

G. Lee, J. Kang, and H. Kim, Combination Chemotherapy With Gemcitabine and Cisplatin as First-Line Treatment for Immunohistochemically Proven Cholangiocarcinoma, American Journal of Clinical Oncology, vol.29, issue.2, pp.127-158, 2006.
DOI : 10.1097/01.coc.0000203742.22828.bb

J. Knox, D. Hedley, and A. Oza, Combining Gemcitabine and Capecitabine in Patients With Advanced Biliary Cancer: A Phase II Trial, Journal of Clinical Oncology, vol.23, issue.10, pp.2332-2340, 2005.
DOI : 10.1200/JCO.2005.51.008

T. Andre, C. Tournigand, and O. Rosmorduc, Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR study, Annals of Oncology, vol.15, issue.9, pp.1339-1382, 2004.
DOI : 10.1093/annonc/mdh351

R. Hoffmann, P. Paprottka, and A. Schon, Transarterial Hepatic Yttrium-90 Radioembolization in Patients with Unresectable Intrahepatic Cholangiocarcinoma: Factors Associated with Prolonged Survival, CardioVascular and Interventional Radiology, vol.11, issue.33, pp.105-121
DOI : 10.1007/s00270-011-0142-x

O. Hyder, J. Marsh, and R. Salem, Intra-arterial Therapy for Advanced Intrahepatic Cholangiocarcinoma: A Multi-institutional Analysis, Annals of Surgical Oncology, vol.141, issue.12, pp.3779-86, 2013.
DOI : 10.1245/s10434-013-3127-y

A. Benson, J. Geschwind, and M. Mulcahy, Radioembolisation for liver metastases: Results from a prospective 151 patient multi-institutional phase II study, European Journal of Cancer, vol.49, issue.15, pp.3122-3152
DOI : 10.1016/j.ejca.2013.05.012

C. Servajean, M. Gilabert, and G. Piana, One case of intrahepatic cholangiocarcinoma amenable to resection after radioembolization, World Journal of Gastroenterology, vol.20, issue.17, pp.5131-5135
DOI : 10.3748/wjg.v20.i17.5131

Y. Wang, J. Li, and Y. Xia, Prognostic Nomogram for Intrahepatic Cholangiocarcinoma After Partial Hepatectomy, Journal of Clinical Oncology, vol.31, issue.9, pp.1188-95
DOI : 10.1200/JCO.2012.41.5984

M. Mavros, K. Economopoulos, V. Alexiou, and T. Pawlik, Treatment and Prognosis for Patients With Intrahepatic Cholangiocarcinoma, JAMA Surgery, vol.149, issue.6, 2014.
DOI : 10.1001/jamasurg.2013.5137

L. De-mestier, G. Manceau, and C. Neuzillet, Primary tumor resection in colorectal cancer with unresectable synchronous metastases: A review, World J Gastrointest Oncol, vol.6, pp.156-69, 2014.